Uranium Royalty (TSE:URC – Get Free Report) had its price target lowered by equities research analysts at Canaccord Genuity Group from C$6.75 to C$6.50 in a note issued to investors on Tuesday, BayStreet.CA reports. The brokerage currently has a “speculative buy” rating on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside of 93.45% from the stock’s previous close.
Uranium Royalty Stock Performance
TSE URC traded up C$0.08 during trading on Tuesday, reaching C$3.36. 156,975 shares of the company traded hands, compared to its average volume of 202,035. Uranium Royalty has a 1-year low of C$2.53 and a 1-year high of C$5.05. The stock’s 50 day moving average price is C$3.00 and its two-hundred day moving average price is C$3.24. The company has a market cap of C$408.24 million, a price-to-earnings ratio of 48.00 and a beta of 1.68.
Uranium Royalty (TSE:URC – Get Free Report) last posted its earnings results on Thursday, September 12th. The company reported C($0.02) earnings per share (EPS) for the quarter. Uranium Royalty had a return on equity of 3.83% and a net margin of 20.29%.
About Uranium Royalty
Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. The company has royalty interests in the McArthur River, Cigar Lake / Waterbury Lake, Roughrider, Russell Lake, Russell Lake south, and Dawn Lake projects in Saskatchewan, Canada; Anderson and San Rafael projects in Arizona; Lance and Reno Creek projects in Wyoming; Church Rock and Roca Honda projects in New Mexico; Dewey-Burdock project in South Dakota; Slick Rock project in Colorado; Langer Heinrich project in Namibia; and Michelin project in Newfoundland and Labrador, Canada; Energy Queen and Whirlwind project in Utah; and Workman Creek projects in Arizona.
See Also
- Five stocks we like better than Uranium Royalty
- Using the MarketBeat Dividend Yield Calculator
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Uranium Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uranium Royalty and related companies with MarketBeat.com's FREE daily email newsletter.